Vertex Pharmaceuticals Inc / Ma financial data

Symbol
VRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
50 Northern Avenue, Boston, MA
State of incorporation
MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 311 % -27.8%
Quick Ratio 23.9 % +32.6%
Debt-to-equity 33.8 % +8.06%
Return On Assets -2.16 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 258M shares -0.06%
Common Stock, Shares, Outstanding 258M shares -0.03%
Entity Public Float 90.7B USD +26.3%
Common Stock, Value, Issued 2.6M USD 0%
Weighted Average Number of Shares Outstanding, Basic 258M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 261M shares +0.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.6B USD +10.1%
Research and Development Expense 3.2B USD +74.1%
Costs and Expenses 10.9B USD +88.6%
Operating Income (Loss) -270M USD -107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 260M USD -94%
Income Tax Expense (Benefit) 739M USD -11.9%
Net Income (Loss) Attributable to Parent -480M USD -114%
Earnings Per Share, Basic -1.84 USD/shares -114%
Earnings Per Share, Diluted -1.99 USD/shares -115%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.24B USD -52.8%
Marketable Securities, Current 1.29B USD +57.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1.75B USD +13.8%
Inventory, Net 1.08B USD +56.8%
Other Assets, Current 84.3M USD +13.3%
Assets, Current 9.8B USD -33.3%
Deferred Income Tax Assets, Net 2.31B USD +33.5%
Operating Lease, Right-of-Use Asset 1.4B USD +350%
Intangible Assets, Net (Excluding Goodwill) 832M USD +37.8%
Goodwill 1.09B USD 0%
Other Assets, Noncurrent 990M USD +108%
Assets 22.2B USD +2.37%
Accounts Payable, Current 396M USD +5.29%
Employee-related Liabilities, Current 295M USD +19.7%
Accrued Liabilities, Current 3.22B USD +10.7%
Liabilities, Current 3.97B USD +10.4%
Operating Lease, Liability, Noncurrent 1.59B USD +348%
Other Liabilities, Noncurrent 933M USD +7.36%
Liabilities 6.61B USD +26.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 28.8M USD
Retained Earnings (Accumulated Deficit) 8.69B USD -5.23%
Stockholders' Equity Attributable to Parent 15.6B USD -5.34%
Liabilities and Equity 22.2B USD +2.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.31B USD +45.2%
Net Cash Provided by (Used in) Financing Activities -358M USD -21.3%
Net Cash Provided by (Used in) Investing Activities -2.14B USD -16.5%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 258M shares -0.03%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.2B USD +1.11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.25B USD -52.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10M USD -9.91%
Deferred Tax Assets, Valuation Allowance 267M USD +12.1%
Deferred Tax Assets, Gross 2.43B USD +31.9%
Operating Lease, Liability 1.66B USD
Payments to Acquire Property, Plant, and Equipment 68.4M USD +62.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -448M USD -113%
Lessee, Operating Lease, Liability, to be Paid 2.79B USD
Operating Lease, Liability, Current 66.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 168M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 167M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 933M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 168M USD
Deferred Tax Assets, Operating Loss Carryforwards 77.4M USD -27.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 616M USD +34%
Lessee, Operating Lease, Liability, to be Paid, Year Four 164M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 53.5M USD +37.9%
Deferred Tax Assets, Net of Valuation Allowance 2.17B USD +34.9%
Share-based Payment Arrangement, Expense 739M USD +52.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%